[Use of thymalin in the complex treatment of patients with cancer of the uterus].
The results of a clinico-immunologic study of thymalin as a component of complex antitumor treatment of 21 cases of cancer of corpus uteri pointed to a pronounced immunomodulating action of the drug on T-cell-mediated immunity. It was inferred that thymalin should be used for immunocorrection in complex treatment for the said neoplasms provided T-cell-mediated immunity is monitored.
D019326:17-alpha-Hydroxyprogesterone; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004958:Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D008875:Middle Aged; D013629:Tamoxifen / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery
D000276:Adjuvants, Immunologic; D006908:Hydroxyprogesterones; D013951:Thymus Hormones; D013629:Tamoxifen; D004958:Estradiol; D019326:17-alpha-Hydroxyprogesterone; C032805:thymalin
Primenenie timalina v kompleksnom lechenii bol'nykh rakom tela matki.